Court, Explained
U.S. Federal District Courts
Back to docket
N.D. Cal.Procedural orderFiled July 8, 2025

Hamzeh v. Pharmavite LLC

Judge
Haywood Gilliam
Docket
4:24-cv-00472
Court
U.S. District Court · Northern District of California
Pages
3

Counsel7 of record
PLAINTIFF
Alan M. Feldman Feldman Shepherd Wohlgelernter Tanner Weinstock & Dodig, LLP
George A. Donnelly Feldman Shepherd Wohlgelernter Tanner Weinstock & Dodig, LLP
Zachary Arbitman Feldman Shepherd Wohlgelernter Tanner Weinstock & Dodig, LLP
Richard Elgar Lyon , III Dovel & Luner LLp
Simon Carlo Franzini Dovel and Luner
DEFENDANT
Juliet Arlene Markowitz Tatro Tekosky Sadwick LLP
Rene Pierre Tatro Tatro Tekosky Sadwick LLP

Counsel of record per CourtListener. Firm names are approximate and have been consolidated across spelling variants.

Civil ProcedureDiscovery
In one sentence

In Hamzeh v. Pharmavite, Judge Gilliam denied Pharmavite’s motion to stay proceedings pending a Ninth Circuit appeal.

Who this affects

The ruling affects Guity Hamzeh, Pharmavite LLC, Nature Made Nutritional Products, and the continuation of the case and discovery.

What happened

In Hamzeh v. Pharmavite LLC, Pharmavite LLC and Nature Made Nutritional Products asked the court to pause the case and discovery until the Ninth Circuit decided an appeal in Bowler v. Nestlé Health Science, U.S., LLC.

The court said the appeal was still in its early stages, oral argument had not been scheduled, and no one could predict when a decision would issue. It also found that waiting could unnecessarily prolong the case and that judicial efficiency therefore weighed against a stay.

Judge Haywood S. Gilliam, Jr. denied the motion to stay. Because the judicial-efficiency issue was decisive, the court did not address the defendants’ other arguments.

The detailed version

For law students, journalists, and other readers who want the full reasoning

Case
Hamzeh v. Pharmavite LLC · No. 4:24-cv-00472
Judge
Haywood Gilliam
Date
July 8, 2025

Background

Defendants Pharmavite LLC and Nature Made Nutritional Products, collectively referred to in the opinion as “Pharmavite,” moved to stay the proceedings and requested a protective order staying discovery until the Ninth Circuit resolved the appeal in Bowler v. Nestlé Health Science, U.S., LLC.

Legal Standard

The court applied the standard for a discretionary stay under Landis v. North American Co. A court considering such a stay weighs: (1) possible harm from granting the stay; (2) hardship or unfairness to a party required to continue; and (3) whether a stay would promote an orderly and efficient resolution by simplifying or complicating the issues, evidence, or legal questions. If there is even a fair possibility that a stay would harm another person, the party requesting the stay must show a clear case of hardship or unfairness.

Analysis

The court declined to stay the case. It noted that the Bowler appeal was in its early stages: although a briefing schedule had been set, oral argument had not been scheduled, and the parties and court could not predict when the Ninth Circuit would issue a decision. The court also stated that the Ninth Circuit might issue a memorandum disposition rather than a controlling decision.

Judicial efficiency was the decisive consideration. The court found that waiting for the appeal could further prolong the matter, which counseled against a stay. Because this factor resolved the motion, the court did not address Pharmavite’s other arguments. The court stated that the parties and the court could assess the effects of any decision in Bowler after the Ninth Circuit ruled.

Disposition

The court denied Pharmavite’s motion to stay the proceedings pending resolution of the Bowler appeal. The order also denied the requested stay of discovery. Judge Haywood S. Gilliam, Jr. entered the order on July 8, 2025.

The authoritative version

Read the full 3-page opinion on CourtListener, the free public archive maintained by the Free Law Project.

Open opinion PDF →
Summary written with AI assistance. See how summaries are made. Spot something wrong? Tell us.